Current landscape and future direction in systemic therapy for renal cell carcinoma (RCC)
by Susanne Osanto
What is the best second-line treatment of advanced renal cell carcinoma (RCC)?
by Axel Merseburger
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma
by Laurence Albiges
S-TRAC Phase III trial of sunitinib as adjuvant therapy in high-risk renal cell cancer patients
by Thomas Powles
ARASENS: Will combining different treatments improve prostate cancer survival?
by Bertrand Tombal